إعلان
إعلان
AVXL
Anavex Life Sciences
4.28
USDبرعاية
+0.01
+0.12%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
4.29
+0.02
+0.47%
تقارير أرباح AVXL
النسبة الإيجابية المفاجئة
AVXL تفوق 24 من 36 آخر التقديرات.
67%
التقرير التالي
بيانات التقرير القادم
٠٥ فبراير ٢٠٢٦
Estimate for Q1 26 (Revenue/ EPS)
--
/-$0.11
التغير الضمني من Q4 25 (Revenue/ EPS)
--
/--
التغير الضمني من Q1 25 (Revenue/ EPS)
--
/-21.43%
Anavex Life Sciences earnings per share and revenue
On ٢٥ نوفمبر ٢٠٢٥, AVXL reported earnings of -0.11 USD per share (EPS) for Q4 25, beating the estimate of -0.15 USD, resulting in a 28.10% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +11.56% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 5 المحللين forecast an EPS of -0.11 USD, with revenue projected to reach -- USD, implying an زيادة of 0.00% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
What were Anavex Life Sciences's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Anavex Life Sciences reported EPS of -$0.11, beating estimates by 28.1%, and revenue of $0.00, 0% as expectations.
How did the market react to Anavex Life Sciences's Q4 2025 earnings?
The stock price moved up 11.56%, changed from $3.46 before the earnings release to $3.86 the day after.
When is Anavex Life Sciences expected to report next?
The next earning report is scheduled for ٠٥ فبراير ٢٠٢٦.
What are the forecasts for Anavex Life Sciences's next earnings report?
Based on 5
المحللين, Anavex Life Sciences is expected to report EPS of -$0.11 and revenue of -- for Q1 2026.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان